Eulerpool Terminal
The edge that pays for itself.
Current Passage Bio forecasts and price targets in August 2026
Ø Analyst Price Targets
40.39 USD
+788.71 %
Median
32.64 USD
+618.15 %
Max
71.40 USD
Min
10.10 USD
Last Price
4.55 USD
Buy
11
Hold
1
Sell
0
The average target price for Passage Bio is 40.39 USD. (+788.71 % above the current price)
The median price target of Passage Bio is 32.64 USD.
Stock analysts from many renowned investment banks are closely examining the Passage Bio stock. They conclude their professional Passage Bio stock analyses with a clear recommendation for the Passage Bio stock. The forecasts and price targets of professional analysts can be a good indicator of how a stock will perform in the next quarter.
| Buy | Hold | Sell | Ø Analyst Price Targets | |
|---|---|---|---|---|
| 2026-02-01 | 11 | 1 | 0 | 40.39 USD |
| 2026-01-01 | 11 | 1 | 0 | 40.39 USD |
| 2025-12-01 | 11 | 1 | 0 | 40.39 USD |
| 2025-12-01 | 11 | 1 | 0 | 40.39 USD |
| 2025-11-01 | 10 | 1 | 0 | 33.15 USD |
| 2025-11-01 | 10 | 1 | 0 | 60.44 USD |
Passage Bio Stock Forecast 2026: Revenue & Earnings Estimates
Analysts expect the following revenue and earnings for Passage Bio in the coming fiscal years:
| Fiscal year | Revenue | Net Income | Earnings per share |
|---|---|---|---|
| 2026e | 2.00 M USD | -33.00 M USD | -10.40 USD |
| 2027e | 45.00 M USD | -30.00 M USD | -9.46 USD |
| 2028e | 31.00 M USD | -28.00 M USD | -8.82 USD |